Olympiad Research’s MetLife MET Stock Holding History

Olympiad Research’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,762	Closed	-$218K	–	123
2025 Q4	$218K	Buy	+2,762	New	+$219K	0.58%	63

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Olympiad Research's MET Position: Q1 2026 in Review

Olympiad Research sold out of MetLife (MET) in Q1 2026, closing a stake of 2,762 shares — an estimated $218K sold.

Olympiad Research first reported a position in MET in Q4 2025 and held it in 1 quarter. The position peaked at $218K in Q4 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Olympiad Research reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
Olympiad Research sold 2,762 MetLife shares in Q1 2026, an estimated $218K.
Olympiad Research first reported a position in MetLife in Q4 2025 and held it in 1 quarter.
Olympiad Research's MetLife position peaked at $218K in Q4 2025.
1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Olympiad Research's 13F filing for Q1 2026, filed 13 May 2026.